Autoinflammatory & rare systemic diseases

Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International Autoinflammatory Disease Alliance (AIDA) Network Still Disease Registry

J RheumatolPublished Multicentre observational registry study

Authors' conclusion

The most common feature was the pericarditis, but a more severe clinical picture was also reported in patients with myocarditis. The latter was associated with increased mortality rate and higher systemic score, identifying patients who should be carefully managed.

Study context

Population
Consecutive patients with Still disease and cardiac involvement (pericarditis, tamponade, myocarditis and/or aseptic endocarditis) in the AIDA Network Still disease registry21.9% children
Participants
73 patients
Exposure
Patients with myocarditis vs patients without myocarditis
Outcome
Cardiac involvement, with a focus on myocarditis, and predictive factors for myocarditis
Methodological detailsinternational, consecutive patients, AIDA Network Still disease registry
  • International
  • Consecutive patients
  • AIDA Network Still disease registry

Main finding

As reported in the abstract

Cardiac manifestations

Pericarditis (most common)

90.4%

Myocarditis

26%

Endocarditis

2.7%

Tamponade

1.4%

Observational data: associations, not effects.

Further findings

Clinical features, myocarditis vs without

Significantly increased frequencies of skin rash and pleuritis, and higher systemic scores, with myocarditis
Higher mortality rate with myocarditis

Independent predictors of myocarditis (regression models)

Skin rash and the systemic score independently predicted myocarditis

Original publication

Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry. J Rheumatol. Published 15 November 2024. doi:10.3899/jrheum.2024-0683

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.